BioCentury
ARTICLE | Clinical News

Macromol oral delivery technology: Starting Phase II trials

May 23, 1994 7:00 AM UTC

Cortecs International Ltd. (DLVRY), U.K. Product: Macromol oral delivery technology for salmon calcitonin, an inhibitor of osteoclasts, the cells that mediate bone breakdown Indication: Osteoporosis a...